At N2Jenomics Lab Pvt. Ltd., we offer a comprehensive suite of Spatial Transcriptomics Sequencing Services that enables researchers to explore gene expression while preserving the spatial organization of tissues. Our advanced spatial multi-omics solutions combine state-of-the-art sequencing and imaging technologies, providing insights into cellular architecture, tissue heterogeneity, and molecular interactions that conventional transcriptomics cannot reveal.
Whether your study focuses on whole-transcriptome profiling in fresh frozen tissues or high-resolution targeted analysis in FFPE samples, our expert team delivers end-to-end support—from experimental design and platform selection to sequencing, bioinformatics, and biological interpretation.
We provide four industry-leading spatial transcriptomics technologies to accommodate diverse research objectives:
Our platform portfolio supports multiple levels of spatial resolution, allowing researchers to select the most appropriate technology for their study.
Our workflows are optimized for a wide range of tissue preservation methods and biological samples, including:
We support research involving human, mouse, plant, animal, and other model or non-model organisms, depending on platform compatibility and project requirements.
N2Jenomics Lab Pvt. Ltd. provides a fully integrated service covering every stage of your spatial transcriptomics project, including:
With cutting-edge technologies, experienced molecular biologists, and a dedicated bioinformatics team, N2Jenomics Lab Pvt. Ltd. empowers researchers to uncover spatial gene expression patterns, cellular interactions, and tissue microenvironments with exceptional precision, enabling breakthrough discoveries in cancer biology, neuroscience, immunology, developmental biology, pathology, and precision medicine.
Traditional bulk RNA sequencing measures the average gene expression across millions of cells, masking the diversity and spatial organization within complex tissues. Although single-cell RNA sequencing (scRNA-seq) can identify individual cell populations, it requires tissue dissociation, resulting in the loss of critical spatial relationships between cells and their surrounding microenvironment.
Spatial transcriptomics overcomes these limitations by combining gene expression profiling with spatial localization, enabling researchers to visualize where genes are expressed while preserving the native architecture of the tissue. This provides a more complete understanding of cellular interactions, tissue organization, and biological function.
Recognized as Nature Methods' "Method of the Year" in 2020, spatial transcriptomics has rapidly evolved into a powerful suite of technologies that integrates sequencing, imaging, and multi-omics approaches. These platforms enable researchers to investigate complex biological systems with unprecedented spatial and molecular resolution.
At N2Jenomics Lab Pvt. Ltd., we offer a complete portfolio of industry-leading spatial transcriptomics platforms, allowing researchers to choose the most appropriate technology for their specific scientific objectives.
Our platform offerings include:
Each spatial technology provides unique strengths. Sequencing-based platforms generate comprehensive, genome-wide expression profiles while maintaining spatial context, making them ideal for tissue-wide discovery studies. Imaging-based approaches deliver highly sensitive visualization of selected transcripts at single-molecule resolution, enabling precise characterization of individual cells and their microenvironments.
By offering multiple complementary technologies under one roof, we help researchers select the most suitable platform based on sample type, resolution requirements, target coverage, and experimental goals. As projects progress, workflows can be seamlessly adapted or expanded without the need to transition to another service provider.
Beyond sequencing, our experienced scientists provide complete project support, including:
With cutting-edge instrumentation, dedicated molecular biology expertise, and advanced bioinformatics capabilities, N2Jenomics Lab Pvt. Ltd. enables researchers to uncover the molecular geography of tissues, revealing how cells interact, organize, and function within their native biological environment across applications in cancer research, neuroscience, immunology, developmental biology, regenerative medicine, and precision healthcare.
Each platform has distinct strengths. Use this table to match your experimental priorities to the right service — or consult our scientific team for a personalized recommendation.
| Feature | 10x Visium FF | 10x Visium HD | 10x Xenium In Situ | Stereo-seq |
|---|---|---|---|---|
| Technology type | Sequencing-based (array) | Sequencing-based (HD array) | Imaging-based (in situ FISH) | Sequencing-based (DNB array) |
| Spot / feature resolution | 55 µm spots | 2 µm bins (single-cell scale) | Subcellular (~0.2 µm) | 220 nm DNBs (subcellular) |
| Transcriptome coverage | Whole transcriptome (poly(A)) | Whole transcriptome (probes) | Targeted panel (up to 5,000 genes) | Whole transcriptome (poly(A) / FFPE probes) |
| Sample compatibility | Fresh frozen (OCT) | Fresh frozen + FFPE | Fresh frozen + FFPE | Fresh frozen (FFPE: V2) |
| Species compatibility | Any with reference genome | Human, mouse (validated) | Human, mouse (panel-dependent) | Any with reference genome |
| Capture area per slide | 6.5 × 6.5 mm (or 11 × 11 mm) | 6.5 × 6.5 mm | Up to 24 mm × 16 mm (multi-section) | Up to 13 × 13 cm (centimeter scale) |
| Single-cell resolution | ✗ (1–10 cells/spot) | ✓ (2 µm ≈ single-cell) | ✓ (subcellular) | ✓ (220 nm, with cell segmentation) |
| Bioinformatics pipeline | Space Ranger + Seurat | Space Ranger HD + Seurat | Xenium Ranger + cell segmentation | SAW (STOmics) + Seurat / Scanpy |
| Best use case | Discovery, non-model organisms, novel spatial biology | Single-cell-resolution spatial atlases, FFPE cohorts | Subcellular localization, validated targeted panels, cell morphology | Large-area tissue mapping, embryo atlases, extreme resolution |
At N2Jenomics Lab Pvt. Ltd., we offer a complete portfolio of industry-leading spatial transcriptomics technologies designed to address a broad range of biological and clinical research applications. Every project follows our comprehensive end-to-end workflow—from sample quality assessment and tissue processing to sequencing, advanced bioinformatics, and publication-ready data delivery.
Whether your goal is whole-transcriptome discovery, single-cell spatial profiling, subcellular transcript localization, or large-scale tissue mapping, our experts help you select the platform best suited to your research objectives.
• Transcript Coverage
• Supported Species
• Sample Compatibility
• Bioinformatics Analysis
Our analysis pipeline includes:
• Ideal Applications
• Spatial Resolution
• Transcript Coverage
• Supported Species
• Sample Compatibility
• Bioinformatics Analysis
Ideal Applications
• Spatial Resolution
• Transcript Coverage
• Supported Species
• Sample Compatibility
• Bioinformatics Analysis
• Ideal Applications
• Spatial Resolution
• Transcript Coverage
• Supported Species
• Sample Compatibility
• Bioinformatics Analysis
• Ideal Applications
Regardless of the platform selected, every project at N2Jenomics Lab Pvt. Ltd. benefits from our integrated workflow, including:
Our multidisciplinary team ensures that each project is optimized for your research objectives, delivering reliable, high-resolution spatial data that accelerates discoveries in cancer biology, neuroscience, immunology, developmental biology, regenerative medicine, pathology, and precision healthcare.
Match your primary research question to the platform best suited to answer it. Most complex projects benefit from a combination of platforms — our scientific team can help design a multi-platform strategy.
| Research Question | Recommended Platform | Why |
|---|---|---|
| I want whole-transcriptome spatial expression in a non-human species | Visium FF | Only poly(A) capture method compatible with any reference genome; no species-specific probe design needed |
| I need single-cell-level spatial resolution from FFPE archives | Visium HD | 2 µm bin size reaches single-cell scale with continuous coverage; CytAssist enables FFPE compatibility |
| I need exact subcellular transcript localization and cell morphology data | Xenium In Situ | Single-molecule FISH imaging at ~200 nm; DAPI-defined cell boundaries; highest spatial precision per transcript |
| I'm mapping an entire embryo or large organ section at high resolution | Stereo-seq | 220 nm resolution + centimeter-scale capture area (up to 13 × 13 cm) — no other platform combines both |
| I want to discover novel spatial biology in a tumor microenvironment | Visium FF + scRNA-seq deconvolution | Unbiased whole-transcriptome spatial map, combined with matched scRNA-seq reference for cell-type resolution |
| I have a validated gene panel and need exact cell counts and morphology | Xenium In Situ | Targeted panel design; single-molecule sensitivity; integrates with DAPI, IF protein staining |
| I need a spatial atlas at single-cell scale with maximum transcriptome depth | Visium HD or Stereo-seq | Both offer near-single-cell resolution genome-wide; Visium HD is better for human/mouse FFPE; Stereo-seq for large-area or non-model applications |
Spatial multi-omics is transforming biological and biomedical research by revealing where genes are expressed, how cells interact, and how tissue architecture influences biological function. By preserving spatial context, researchers can investigate complex cellular ecosystems that cannot be resolved using conventional bulk or single-cell sequencing alone.
At N2Jenomics Lab Pvt. Ltd., our comprehensive portfolio of Visium™, Visium HD™, Xenium™ In Situ, and Stereo-seq platforms enables researchers to select the most appropriate technology for virtually any spatial biology application.
Cancer tissues consist of diverse cell populations that continuously communicate with one another. Spatial transcriptomics enables researchers to visualize the organization of tumor cells, immune infiltrates, stromal components, and surrounding healthy tissue within their native microenvironment.
Our spatial analysis workflows support:
• Platform selection is optimized according to the desired spatial resolution, sample type, and research objectives.
The nervous system contains highly specialized cell populations arranged in complex anatomical structures. Spatial transcriptomics provides unprecedented insight into neuronal organization while preserving tissue architecture.
Applications include:
By combining whole-transcriptome sequencing with single-cell and subcellular imaging technologies, researchers can generate highly detailed spatial maps of the nervous system.
Understanding embryonic development requires monitoring gene expression across both time and space. Spatial transcriptomics allows researchers to visualize developmental processes while maintaining the structural organization of tissues.
Common applications include:
• Large-area imaging platforms such as Stereo-seq enable high-resolution mapping across entire embryos and developing organs.
Spatial technologies have significantly expanded the molecular analysis of archived clinical specimens, particularly FFPE (Formalin-Fixed Paraffin-Embedded) tissues.
Researchers can investigate:
These capabilities allow valuable hospital and biobank specimens to be revisited using modern spatial genomics approaches.
Combining complementary technologies provides a more comprehensive understanding of complex biological systems.
Our integrated workflows can incorporate:
• Advanced bioinformatics pipelines integrate these datasets to identify cellular interactions, signaling pathways, and molecular mechanisms with greater biological accuracy.
At N2Jenomics Lab Pvt. Ltd., every spatial transcriptomics project follows a carefully designed workflow that ensures high-quality data generation, rigorous quality control, and comprehensive scientific support from project initiation through publication.

Every project begins with a detailed consultation to understand your research objectives and experimental requirements.
Our experts assist with:
All submitted specimens undergo comprehensive quality evaluation before processing.
Quality assessment includes:
If a sample does not meet quality requirements, our team provides a detailed evaluation and recommendations before proceeding.
Following successful quality control, platform-specific workflows are performed using validated laboratory protocols.
Depending on the selected technology, this stage includes:
• Sequencing-based platforms utilize advanced Illumina or DNBSEQ systems, while imaging-based workflows employ dedicated high-resolution spatial imaging instruments.
Raw data are processed using platform-specific computational pipelines to generate accurate spatial gene expression datasets.
Primary analyses include:
• Every dataset undergoes stringent quality review before downstream biological analysis begins.
Our experienced bioinformatics scientists perform comprehensive downstream analyses tailored to each project.
Available analyses include:
• Final deliverables include publication-ready figures, comprehensive reports, processed datasets, and interactive visualization files compatible with leading spatial genomics software.
Our commitment extends beyond data delivery.
We provide continued scientific support through:
By combining advanced spatial transcriptomics technologies with experienced molecular biologists, bioinformaticians, and dedicated project managers, N2Jenomics Lab Pvt. Ltd. delivers complete spatial multi-omics solutions that help researchers uncover the spatial organization of biology and accelerate discoveries in oncology, neuroscience, immunology, developmental biology, pathology, regenerative medicine, and precision healthcare.
Selecting the most suitable platform depends on your research objectives, sample type, desired spatial resolution, and the level of transcriptome coverage required.
Key considerations include:
Our scientific team will evaluate your samples and research goals to recommend the most appropriate platform—or a combination of platforms—for your study.
Yes. Many advanced spatial biology studies combine complementary platforms to obtain a more comprehensive view of tissue organization and gene expression.
For example:
Our team manages tissue sectioning, experimental coordination, and cross-platform bioinformatics integration to ensure consistent, biologically meaningful results.
High-quality tissue preservation is essential for obtaining reliable spatial gene expression data.
• Fresh Frozen Samples
• FFPE Samples
Yes. Several of our spatial transcriptomics platforms are well suited for non-model species.
Platforms such as Visium™ Spatial Gene Expression and Stereo-seq can be applied to a wide variety of organisms provided that suitable reference genome or transcriptome resources are available for downstream analysis.
These technologies have broad applications in:
• For imaging-based platforms such as Visium HD™ and Xenium™ In Situ, species availability depends on validated or custom-designed probe panels. Our experts can advise on feasibility for your organism of interest.
Each spatial multi-omics project includes comprehensive laboratory and bioinformatics deliverables designed to support downstream research and publication.
Typical deliverables include:
• Interactive data formats compatible with leading spatial analysis software are also available to facilitate collaborative exploration and downstream interpretation.
Absolutely. In addition to our standard analysis pipelines, we offer a wide range of advanced bioinformatics services tailored to your research objectives.
Customized analyses may include:
Our experienced bioinformatics team works closely with researchers to ensure that every dataset is analyzed using the most appropriate computational approaches for meaningful biological interpretation.